Showing results (211-220 of 242) with videos related to

Sort By:
Pageof 25
The Canadian Journal of Urology|August 21, 2018
Urinary pH and the risk of recurrence in patients with non-muscle invasive bladder cancerBenjamin V Stone, Abimbola Ayangbesan, Benjamin L Taylor, et al.
Urology|November 19, 2013
180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parametersPierre-Alain Hueber, Daniel Liberman, Tal Ben-Zvi, et al.
BJU International|June 5, 2018
Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trialMark Plante, Peter Gilling, Neil Barber, et al.
The Canadian Journal of Urology|April 19, 2021
Focal bladder neck cautery associated with low rate of post-Aquablation bleedingDean S Elterman, Susan Foller, Burkhard Ubrig, et al.
The Journal of Urology|January 24, 2018
WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation® vs Transurethral Resection of the Prostate in Benign Prostatic HyperplasiaPeter Gilling, Neil Barber, Mohamed Bidair, et al.
The Canadian Journal of Urology|February 18, 2020
Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trialPeter Gilling, Neil Barber, Mohamed Bidair, et al.
Advances in Therapy|April 28, 2019
Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements SustainedPeter Gilling, Neil Barber, Mohamed Bidair, et al.
The Journal of Sexual Medicine|January 20, 2025
Preservation of sexual function with Optilume-a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasiaOlivia Copelan, Jared Moss, Sheldon Freedman, et al.
Minerva Urology and Nephrology|November 17, 2020
Outcomes of combination therapy with daily tadalafil 5 mg plus tamsulosin 0.4 mg to treat lower urinary tract symptoms and erectile dysfunction in men with or without metabolic syndromeArcangelo Sebastianelli, Simone Morselli, Pietro Spatafora, et al.
European Urology Focus|October 14, 2019
Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational TrialArcangelo Sebastianelli, Pietro Spatafora, Jacopo Frizzi, et al.
Pageof 25